AudioBoom Player

DYOR Disclaimer

If you find this podcast useful please give it a rating and review on iTunes by clicking here

Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app


On today's Vox Markets Podcast: Arix Bioscience, Alba Mineral Resources and Vadim Alexander on Polarean Imaging

Arix Bioscience logo

Jonathan Tobin, Managing Director of Arix Bioscience #ARIX  talks about one of their portfolio companies, Artios Pharma, that's announced global strategic collaboration with Merck that could be worth $ billions.

Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting-edge advances in life sciences. We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.


ALBA MINERALS RESOURCES LOGO

George Frangeskides, Executive Chairman of Alba Mineral Resources #ALBA  discusses a "potentially significant discovery" during its drilling campaign at the Clogau Gold Mine in Wales.

Alba Mineral Resources plc is a mineral exploration and development company with a diversified portfolio of mining assets and oil & gas investments. Alba owns mineral exploration projects in Greenland (graphite, ilmenite, base metals, gold and cobalt), Wales (gold) and Ireland (base metals), as well as investments in the UK onshore oil & gas sector. We will deliver shareholder value by identifying and securing undervalued assets, often with previous production history and where there is serious potential for discovering further unexploited resources alongside the existing mine site.

(Interview starts at 13 minutes 11 seconds)


Vadim Alexandre, Head of Healthcare at SP Angel discusses how in research Polarean Imaging's #POLX  technology highlighted lung abnormalities in patients suffering with Covid-19.

(Interview starts at 20 minutes 52 seconds)